Ariana Pharma

Ariana Pharma is a private, Paris-based company that operates as an AI/ML and drug development services provider. Its core offering is the KEM® explainable AI platform, which analyzes diverse data sets (clinical, omics, RWE) to de-risk and personalize clinical development for pharmaceutical partners. With a seasoned leadership team from pharma and tech, the company focuses on identifying patient subgroups, optimal endpoints, and synergistic drug combinations, positioning itself as a strategic enabler in the precision medicine era rather than a traditional therapeutic developer.

KEM® (Knowledge Extraction and Management) Explainable Artificial Intelligence (eXp.AI) platform. It analyzes and integrates complex, multi-dimensional data sets (clinical, omics, RWE, etc.) to identify patient subgroups, optimal clinical endpoints, and synergistic drug combinations with transparent, logical rules.

Ariana competes in a crowded field of AI/ML drug discovery companies (e.g., Exscientia, Recursion, BenevolentAI) and large tech entrants. Its primary differentiation is its focus on explainable AI (eXp.AI) for clinical development optimization and decision support, rather than early-stage discovery alone.